Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Biliary Tract Diseases

Free Subscription Articles published in PLoS One Retrieve available abstracts of 66 articles: HTML format Text format

Single Articles

January 2018
1. ZENOUZI R, von der Gablentz J, Heldmann M, Gottlich M, et al
   Patients with primary biliary cholangitis and fatigue present with depressive symptoms and selected cognitive deficits, but with normal attention performance and brain structure.
   PLoS One. 2018;13:e0190005.
   PubMed     Text format     Abstract available
   
   
   
2. IIDA T, Kaneto H, Wagatsuma K, Sasaki H, et al
   Efficacy and safety of endoscopic procedures for common bile duct stones in patients aged 85 years or older: A retrospective study.
   PLoS One. 2018;13:e0190665.
   PubMed     Text format     Abstract available
   
   
   
3. PERALDO-NEIA C, Cavalloni G, Fenocchio E, Cagnazzo C, et al
   Prognostic and predictive role of EGFR pathway alterations in biliary cancer patients treated with chemotherapy and anti-EGFR.
   PLoS One. 2018;13:e0191593.
   PubMed     Text format     Abstract available
   
   
   
4. GOOKIN JL, Mathews KG, Cullen J, Seiler G, et al
   Qualitative metabolomics profiling of serum and bile from dogs with gallbladder mucocele formation.
   PLoS One. 2018;13:e0191076.
   PubMed     Text format     Abstract available
   
   
   
5. LEE HS, Chung MJ, Park JY, Bang S, et al
   Urgent endoscopic retrograde cholangiopancreatography is not superior to early ERCP in acute biliary pancreatitis with biliary obstruction without cholangitis.
   PLoS One. 2018;13:e0190835.
   PubMed     Text format     Abstract available
   
   
   
6. NGUYEN HH, Shaheen AA, Baeza N, Lytvyak E, et al
   Evaluation of classical and novel autoantibodies for the diagnosis of Primary Biliary Cholangitis-Autoimmune Hepatitis Overlap Syndrome (PBC-AIH OS).
   PLoS One. 2018;13:e0193960.
   PubMed     Text format     Abstract available
   
   
   
7. ANDRES A, Montano-Loza A, Greiner R, Uhlich M, et al
   A novel learning algorithm to predict individual survival after liver transplantation for primary sclerosing cholangitis.
   PLoS One. 2018;13:e0193523.
   PubMed     Text format     Abstract available
   
   
   
8. SHAHEEN AA, Kaplan GG, Almishri W, Vallerand I, et al
   The impact of depression and antidepressant usage on primary biliary cholangitis clinical outcomes.
   PLoS One. 2018;13:e0194839.
   PubMed     Text format     Abstract available
   
   
   
9. BIAN S, Chen H, Wang L, Fei Y, et al
   Cardiac involvement in patients with primary biliary cholangitis: A 14-year longitudinal survey-based study.
   PLoS One. 2018;13:e0194397.
   PubMed     Text format     Abstract available
   
   
   
10. LIAO CY, Chung CH, Chu P, Wei KY, et al
    Increased risk of osteoporosis in patients with primary biliary cirrhosis.
    PLoS One. 2018;13:e0194418.
    PubMed     Text format     Abstract available
    
    
    
11. KELLER S, Aigner A, Zenouzi R, Kim AC, et al
    Association of gadolinium-enhanced magnetic resonance imaging with hepatic fibrosis and inflammation in primary sclerosing cholangitis.
    PLoS One. 2018;13:e0193929.
    PubMed     Text format     Abstract available
    
    
    
12. KANG J, Lee SH, Son JH, Lee JW, et al
    Body mass index and weight change during initial period of chemotherapy affect survival outcome in advanced biliary tract cancer patients.
    PLoS One. 2018;13:e0195118.
    PubMed     Text format     Abstract available
    
    
    
13. WIELDERS CLC, van Nierop P, Vormer TL, Foijer F, et al
    RNAi screening of subtracted transcriptomes reveals tumor suppression by taurine-activated GABAA receptors involved in volume regulation.
    PLoS One. 2018;13:e0196979.
    PubMed     Text format     Abstract available
    
    
    
14. LIU T, Wang W, Ji Y, Wang Y, et al
    Association between different combination of measures for obesity and new-onset gallstone disease.
    PLoS One. 2018;13:e0196457.
    PubMed     Text format     Abstract available
    
    
    
15. FRYBOVA B, Drabek J, Lochmannova J, Douda L, et al
    Cholelithiasis and choledocholithiasis in children; risk factors for development.
    PLoS One. 2018;13:e0196475.
    PubMed     Text format     Abstract available
    
    
    
16. RATTAY S, Graf D, Kislat A, Homey B, et al
    Anti-inflammatory consequences of bile acid accumulation in virus-infected bile duct ligated mice.
    PLoS One. 2018;13:e0199863.
    PubMed     Text format     Abstract available
    
    
    
17. SILAKIT R, Kitirat Y, Thongchot S, Loilome W, et al
    Potential role of HIF-1-responsive microRNA210/HIF3 axis on gemcitabine resistance in cholangiocarcinoma cells.
    PLoS One. 2018;13:e0199827.
    PubMed     Text format     Abstract available
    
    
    
18. ABE K, Takahashi A, Fujita M, Imaizumi H, et al
    Dysbiosis of oral microbiota and its association with salivary immunological biomarkers in autoimmune liver disease.
    PLoS One. 2018;13:e0198757.
    PubMed     Text format     Abstract available
    
    
    
19. IRANMANESH P, Tobler O, De Sousa S, Andres A, et al
    Feasibility, benefit and risk of systematic intraoperative cholangiogram in patients undergoing emergency cholecystectomy.
    PLoS One. 2018;13:e0199147.
    PubMed     Text format     Abstract available
    
    
    
20. SAMUEL S, Mukherjee S, Ammannagari N, Pokuri VK, et al
    Clinicopathological characteristics and outcomes of rare histologic subtypes of gallbladder cancer over two decades: A population-based study.
    PLoS One. 2018;13:e0198809.
    PubMed     Text format     Abstract available
    
    
    
21. NA SK, Choi GH, Lee HC, Shin YM, et al
    The effectiveness of transarterial chemoembolization in recurrent hepatocellular-cholangiocarcinoma after resection.
    PLoS One. 2018;13:e0198138.
    PubMed     Text format     Abstract available
    
    
    
22. KRUK B, Liebe R, Milkiewicz M, Wunsch E, et al
    PNPLA3 p.I148M and TM6SF2 p.E167K variants do not predispose to liver injury in cholestatic liver diseases: A prospective analysis of 178 patients with PSC.
    PLoS One. 2018;13:e0202942.
    PubMed     Text format     Abstract available
    
    
    
23. PEISELER M, Reiners D, Pinnschmidt HO, Sebode M, et al
    Risk of endoscopic biliary interventions in primary sclerosing cholangitis is similar between patients with and without cirrhosis.
    PLoS One. 2018;13:e0202686.
    PubMed     Text format     Abstract available
    
    
    
24. GABBIA D, Pozzo L, Zigiotto G, Roverso M, et al
    Dexamethasone counteracts hepatic inflammation and oxidative stress in cholestatic rats via CAR activation.
    PLoS One. 2018;13:e0204336.
    PubMed     Text format     Abstract available
    
    
    
25. DE BARI B, Breuneval T, Zeverino M, Godin S, et al
    Hepatobiliary scintigraphy allows the evaluation of short-term functional toxicity of liver stereotactic body radiotherapy: Results of a pilot study.
    PLoS One. 2018;13:e0204013.
    PubMed     Text format     Abstract available
    
    
    
26. LIMPAWATTANA P, Theerakulpisut D, Wirasorn K, Sookprasert A, et al
    The impact of skeletal muscle mass on survival outcome in biliary tract cancer patients.
    PLoS One. 2018;13:e0204985.
    PubMed     Text format     Abstract available
    
    
    
27. SILVA VIEIRA M, Arthurs CJ, Hussain T, Razavi R, et al
    Patient-specific modeling of right coronary circulation vulnerability post-liver transplant in Alagille's syndrome.
    PLoS One. 2018;13:e0205829.
    PubMed     Text format     Abstract available
    
    
    
28. HANDGRAAF HJM, Sibinga Mulder BG, Shahbazi Feshtali S, Boogerd LSF, et al
    Staging laparoscopy with ultrasound and near-infrared fluorescence imaging to detect occult metastases of pancreatic and periampullary cancer.
    PLoS One. 2018;13:e0205960.
    PubMed     Text format     Abstract available
    
    
    
29. LAMARCA A, Galdy S, Barriuso J, Moghadam S, et al
    The HER3 pathway as a potential target for inhibition in patients with biliary tract cancers.
    PLoS One. 2018;13:e0206007.
    PubMed     Text format     Abstract available
    
    
    
30. NAKAMOTO S, Kumamoto Y, Igarashi K, Fujiyama Y, et al
    Methylated promoter DNA of CDO1 gene and preoperative serum CA19-9 are prognostic biomarkers in primary extrahepatic cholangiocarcinoma.
    PLoS One. 2018;13:e0205864.
    PubMed     Text format     Abstract available
    
    
    
31. KIM EJ, Chung DH, Kim YJ, Kim YS, et al
    Endobiliary radiofrequency ablation for distal extrahepatic cholangiocarcinoma: A clinicopathological study.
    PLoS One. 2018;13:e0206694.
    PubMed     Text format     Abstract available
    
    
    
32. RAU M, Schmitt J, Berg T, Kremer AE, et al
    Serum IP-10 levels and increased DPPIV activity are linked to circulating CXCR3+ T cells in cholestatic HCV patients.
    PLoS One. 2018;13:e0208225.
    PubMed     Text format     Abstract available
    
    
    January 2017
33. ZEC S, Popovic D, Matovic V, Nikolic V, et al
    Translation and validation of the Serbian primary biliary cholangitis-40 questionnaire.
    PLoS One. 2017;12:e0175697.
    PubMed     Text format     Abstract available
    
    
    
34. HUSZAR O, Kokas B, Matrai P, Hegyi P, et al
    Meta-Analysis of the Long Term Success Rate of Different Interventions in Benign Biliary Strictures.
    PLoS One. 2017;12:e0169618.
    PubMed     Text format     Abstract available
    
    
    
35. REUKEN PA, Torres D, Baier M, Loffler B, et al
    Risk Factors for Multi-Drug Resistant Pathogens and Failure of Empiric First-Line Therapy in Acute Cholangitis.
    PLoS One. 2017;12:e0169900.
    PubMed     Text format     Abstract available
    
    
    
36. UDOMSINPRASERT W, Kitkumthorn N, Mutirangura A, Chongsrisawat V, et al
    Association between Promoter Hypomethylation and Overexpression of Autotaxin with Outcome Parameters in Biliary Atresia.
    PLoS One. 2017;12:e0169306.
    PubMed     Text format     Abstract available
    
    
    
37. NELSON SM, Gao YT, Nogueira LM, Shen MC, et al
    Diet and biliary tract cancer risk in Shanghai, China.
    PLoS One. 2017;12:e0173935.
    PubMed     Text format     Abstract available
    
    
    
38. CHEN JH, Borges M
    Histopathology and enhanced detection of tumor invasion of peritoneal membranes.
    PLoS One. 2017;12:e0173833.
    PubMed     Text format     Abstract available
    
    
    
39. ZHANG BB, Yan C, Fang F, Du Y, et al
    Increased hepatic Th2 and Treg subsets are associated with biliary fibrosis in different strains of mice caused by Clonorchis sinensis.
    PLoS One. 2017;12:e0171005.
    PubMed     Text format     Abstract available
    
    
    
40. DE LOMBAERDE S, Neyt S, Kersemans K, Verhoeven J, et al
    Synthesis, in vitro and in vivo evaluation of 3beta-[18F]fluorocholic acid for the detection of drug-induced cholestasis in mice.
    PLoS One. 2017;12:e0173529.
    PubMed     Text format     Abstract available
    
    
    
41. CHO S, Lee TS, Song IH, Kim AR, et al
    Combination of anti-L1 cell adhesion molecule antibody and gemcitabine or cisplatin improves the therapeutic response of intrahepatic cholangiocarcinoma.
    PLoS One. 2017;12:e0170078.
    PubMed     Text format     Abstract available
    
    
    
42. ESTIU MC, Frailuna MA, Otero C, Dericco M, et al
    Relationship between early onset severe intrahepatic cholestasis of pregnancy and higher risk of meconium-stained fluid.
    PLoS One. 2017;12:e0176504.
    PubMed     Text format     Abstract available
    
    
    
43. KEMPINSKA-PODHORODECKA A, Milkiewicz M, Jablonski D, Milkiewicz P, et al
    ApaI polymorphism of vitamin D receptor affects health-related quality of life in patients with primary sclerosing cholangitis.
    PLoS One. 2017;12:e0176264.
    PubMed     Text format     Abstract available
    
    
    
44. YAGAI T, Matsui S, Harada K, Inagaki FF, et al
    Expression and localization of sterile alpha motif domain containing 5 is associated with cell type and malignancy of biliary tree.
    PLoS One. 2017;12:e0175355.
    PubMed     Text format     Abstract available
    
    
    
45. QU X, Sheng J, Shen L, Su J, et al
    Autophagy inhibitor chloroquine increases sensitivity to cisplatin in QBC939 cholangiocarcinoma cells by mitochondrial ROS.
    PLoS One. 2017;12:e0173712.
    PubMed     Text format     Abstract available
    
    
    
46. RAO ZZ, Zhang XW, Ding YL, Yang MY, et al
    miR-148a-mediated estrogen-induced cholestasis in intrahepatic cholestasis of pregnancy: Role of PXR/MRP3.
    PLoS One. 2017;12:e0178702.
    PubMed     Text format     Abstract available
    
    
    
47. SHNEIDER BL, Moore J, Kerkar N, Magee JC, et al
    Initial assessment of the infant with neonatal cholestasis-Is this biliary atresia?
    PLoS One. 2017;12:e0176275.
    PubMed     Text format     Abstract available
    
    
    
48. IINO C, Shimoyama T, Igarashi T, Aihara T, et al
    Biliary drainage improves the predictive value of modified Glasgow Prognostic Scores in inoperable pancreatic cancer.
    PLoS One. 2017;12:e0178777.
    PubMed     Text format     Abstract available
    
    
    
49. GRANATA V, Fusco R, Catalano O, Avallone A, et al
    Diagnostic accuracy of magnetic resonance, computed tomography and contrast enhanced ultrasound in radiological multimodality assessment of peribiliary liver metastases.
    PLoS One. 2017;12:e0179951.
    PubMed     Text format     Abstract available
    
    
    
50. LIN WC, Lin HH, Hung CY, Shih SC, et al
    Clinical endoscopic management and outcome of post-endoscopic sphincterotomy bleeding.
    PLoS One. 2017;12:e0177449.
    PubMed     Text format     Abstract available
    
    
    
51. WANG C, Yang Y, Sun D, Jiang Y, et al
    Prognosis of hepatocellular carcinoma patients with bile duct tumor thrombus after hepatic resection or liver transplantation in Asian populations: A meta-analysis.
    PLoS One. 2017;12:e0176827.
    PubMed     Text format     Abstract available
    
    
    
52. KATO S, Chinen K, Shinoura S, Kikuchi K, et al
    Predictors for bile duct stone recurrence after endoscopic extraction for naive major duodenal papilla: A cohort study.
    PLoS One. 2017;12:e0180536.
    PubMed     Text format     Abstract available
    
    
    
53. LI Z, Lin B, Lin G, Wu Y, et al
    Circulating FGF19 closely correlates with bile acid synthesis and cholestasis in patients with primary biliary cirrhosis.
    PLoS One. 2017;12:e0178580.
    PubMed     Text format     Abstract available
    
    
    
54. PEREIRA P, Aho V, Arola J, Boyd S, et al
    Bile microbiota in primary sclerosing cholangitis: Impact on disease progression and development of biliary dysplasia.
    PLoS One. 2017;12:e0182924.
    PubMed     Text format     Abstract available
    
    
    
55. JEE J, Mourya R, Shivakumar P, Fei L, et al
    Cxcr2 signaling and the microbiome suppress inflammation, bile duct injury, and the phenotype of experimental biliary atresia.
    PLoS One. 2017;12:e0182089.
    PubMed     Text format     Abstract available
    
    
    
56. ADEYEMI O, Alvarez-Laviada A, Schultz F, Ibrahim E, et al
    Ursodeoxycholic acid prevents ventricular conduction slowing and arrhythmia by restoring T-type calcium current in fetuses during cholestasis.
    PLoS One. 2017;12:e0183167.
    PubMed     Text format     Abstract available
    
    
    
57. WANG X, Wen X, Zhou J, Qi Y, et al
    MicroRNA-223 and microRNA-21 in peripheral blood B cells associated with progression of primary biliary cholangitis patients.
    PLoS One. 2017;12:e0184292.
    PubMed     Text format     Abstract available
    
    
    
58. FAGAGNINI S, Heinrich H, Rossel JB, Biedermann L, et al
    Risk factors for gallstones and kidney stones in a cohort of patients with inflammatory bowel diseases.
    PLoS One. 2017;12:e0185193.
    PubMed     Text format     Abstract available
    
    
    
59. YE Y, Li Z, Feng Q, Chen Z, et al
    Downregulation of microRNA-145 may contribute to liver fibrosis in biliary atresia by targeting ADD3.
    PLoS One. 2017;12:e0180896.
    PubMed     Text format     Abstract available
    
    
    
60. PETRICK JL, Yang B, Altekruse SF, Van Dyke AL, et al
    Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: A population-based study in SEER-Medicare.
    PLoS One. 2017;12:e0186643.
    PubMed     Text format     Abstract available
    
    
    
61. LEE S, Kweon OK, Kim WH
    Associations between serum leptin levels, hyperlipidemia, and cholelithiasis in dogs.
    PLoS One. 2017;12:e0187315.
    PubMed     Text format     Abstract available
    
    
    
62. IGARASHI K, Yamashita K, Katoh H, Kojima K, et al
    Prognostic significance of promoter DNA hypermethylation of the cysteine dioxygenase 1 (CDO1) gene in primary gallbladder cancer and gallbladder disease.
    PLoS One. 2017;12:e0188178.
    PubMed     Text format     Abstract available
    
    
    
63. PINHEIRO D, Leiros L, Dau JBT, Stumbo AC, et al
    Cytokines, hepatic cell profiling and cell interactions during bone marrow cell therapy for liver fibrosis in cholestatic mice.
    PLoS One. 2017;12:e0187970.
    PubMed     Text format     Abstract available
    
    
    January 2016
64. HUANG SG, Guo WL, Wang J, Sheng M, et al
    Factors Interfering with Delineation on MRCP of Pancreaticobiliary Maljunction in Paediatric Patients.
    PLoS One. 2016;11:e0154178.
    PubMed     Text format     Abstract available
    
    
    
65. EHLKEN H, Wroblewski R, Corpechot C, Arrive L, et al
    Validation of Transient Elastography and Comparison with Spleen Length Measurement for Staging of Fibrosis and Clinical Prognosis in Primary Sclerosing Cholangitis.
    PLoS One. 2016;11:e0164224.
    PubMed     Text format     Abstract available
    
    
    
66. MANTEL HT, Westerkamp AC, Adam R, Bennet WF, et al
    Strict Selection Alone of Patients Undergoing Liver Transplantation for Hilar Cholangiocarcinoma Is Associated with Improved Survival.
    PLoS One. 2016;11:e0156127.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Biliary Tract Diseases is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: